DiscoverAcademicCME Podcast
AcademicCME Podcast
Claim Ownership

AcademicCME Podcast

Author: Patrick Hayes

Subscribed: 0Played: 2
Share
© Patrick Hayes

Description

Enjoy Jointly Accredited Continuing Medical Education podcasts developed by AcademicCME in several advancing disease states. These programs are developed to bring the practicing clinician current with the latest science and provide optimal strategies on applying this science to practice
57 Episodes
Reverse
Updating the Efficacy and Safety Experience of IL-17 Inhibitors

Updating the Efficacy and Safety Experience of IL-17 Inhibitors

2026-01-2240:00

This activity was supported by an educational grant from UCB Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://academiccme.com/courses/il17pod/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 14, 2026.
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies

Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies

2025-12-1154:38

This activity was supported by an educational grant from Amgen. Please go to  ⁠academiccme.com/lipidpod25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 25, 2026.
Update on Long-Acting Nebulized Bronchodilators for Guidance-Based Maintenance for Patients with COPD

Update on Long-Acting Nebulized Bronchodilators for Guidance-Based Maintenance for Patients with COPD

2025-12-1132:56

This activity was supported by an educational grant from Viatris Specialty LLC. Please go to  ⁠⁠academiccme.com/epccopdpod2⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 29, 2026.
Therapeutic Update on COPD with Type 2 Inflammation

Therapeutic Update on COPD with Type 2 Inflammation

2025-11-2526:21

This activity was supported by an educational grant from GSK. Please go to  academiccme.com/epccopd1pod and complete the evaluation to receive your CE/CME Credit. Credit is available through September 29, 2026.
Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making

Updates on FcRn Blockers for Patients With Myasthenia Gravis: Personalized Treatment Strategies and Shared Decision Making

2025-11-2401:03:18

This activity was supported by an educational grant from argenx. Credit is available through May 4, 2026.
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis

AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis

2025-11-1752:08

This activity was supported by an educational grant from Vor Bio. Please go to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://academiccme.com/MG-AANEM-25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 4, 2026.
ESC 2025: Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering

ESC 2025: Conference Review and Analysis of Relevant Data Pertaining to LDL-C Lowering

2025-11-1730:24

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://academiccme.com/front-matter/esc25-2/⁠⁠⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through October 20, 2026.
Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

2025-10-2801:13:27

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠ academiccme.com/ccrwestsle⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.
Clinical Update on Non-Cystic Fibrosis Bronchiectasis: Strategies to Manage Exacerbations and Lung Function

Clinical Update on Non-Cystic Fibrosis Bronchiectasis: Strategies to Manage Exacerbations and Lung Function

2025-10-2825:58

This activity was supported by an educational grant from Insmed. Please go to ⁠ https://academiccme.com/epcncfbepod/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through September 7, 2026.
Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia

Foundational Review of Standards of Care for At-Risk Patients with Dyslipidemia

2025-08-2152:12

This activity was supported by an educational grant from Merck & Co., Inc. Please go to ⁠⁠⁠⁠⁠https://academiccme.com/front-matter/esc25-1/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through August 20, 2026.
Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis

Review of McDonald Criteria 2024 Updates for the Management of Patients with Multiple Sclerosis

2025-07-3125:09

This activity was supported by an educational grant from EMD Serono. Please go to ⁠⁠academiccme.com/McDonaldPod and complete the evaluation to receive your CE/CME Credit. Credit is available through October 23, 2025.
Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists

Implications of Obstructive Hypertrophic Cardiomyopathy (oHCM) for Heart Failure Specialists

2025-07-1840:12

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠academiccme.com/HFPod and complete the evaluation to receive your CE/CME Credit. Credit is available through May 15, 2026.
ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

ACC 2025 Conference Review and Analysis: Therapeutic Advances in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

2025-07-1649:24

This activity was supported by an educational grant from Alnylam Pharmaceuticals. Please go to ⁠http://academiccme.com/ATTRPod and complete the evaluation to receive your CE/CME Credit. Credit is available through June 25, 2026.
Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies

2025-03-1736:38

This activity was supported by an educational grant from Insmed. Please go to academiccme.com/EPCNCFBE and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

2025-03-1738:09

This activity was supported by an educational grant from Merck & Co., Inc.. Please go to  ⁠academiccme.com/EPCPAH and complete the evaluation to receive your CE/CME Credit. Credit is available through September 19, 2025.
Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD

Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD

2024-12-0329:06

This activity was supported by an educational grant from Mylan Specialty L.P., a Viatris Company. Please go to  ⁠academiccme.com/front-matter/copd-podcast/ and complete the evaluation to receive your CE/CME Credit. Credit is available through December 2, 2025.
DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria

DEARA: Blocking 2 Different Renal Receptors to Reduce Proteinuria

2024-11-2126:46

This activity was supported by an educational grant from Travere Therapeutics. Please go to ⁠https://academiccme.com/CKDCE3/⁠ and complete the evaluation to receive your CE/CME Credit. Credit is available through November 21, 2025.
PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy

PBC Treatment in Practice: Optimizing Second Line & Symptom Therapy

2024-11-0532:11

This activity was supported by an educational grant from Ipsen. Please go to  ⁠academiccme.com/PBCCME⁠⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
Clinical Trial Data Review for PBC Therapeutics

Clinical Trial Data Review for PBC Therapeutics

2024-10-1731:09

This activity was supported by an educational grant from Ipsen. Please go to  ⁠academiccme.com/PBCCME⁠⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease

PBC, Science, Diagnostic Strategies, Optimal Treatment Timing, and Burden of Disease

2024-10-1637:57

This activity was supported by an educational grant from Ipsen. Please go to  academiccme.com/PBCCME⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through July 15, 2025.
loading
Comments 
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States